Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review
Brain Sciences · 19.02.2025 · 15 (2) · 215
DOI: 10.3390/brainsci15020215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 19.02.2025. Verfasst von Maryam N ALNasser und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Science, King Faisal University, P.O. Box No. 400, Al-Ahsa 31982, Saudi Arabia. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive decline, primarily due to dysfunction of acetylcholine caused by acetylcholinesterase and butyrylcholinesterase. While synthetic cholinesterase inhibitors like donepezil, rivastigmine, and galantamine are commonly used, they have notable side effects, prompting interest in natural alternatives. Medicinal plants, rich in bioactive compounds like flavonoids and alkaloids, have shown potential as cholinesterase inhibitors with additional antioxidants and anti-inflammatory benefits. This study aimed to evaluate the cholinesterase-inhibiting effects of various plant species and their compounds to identify new therapeutic candidates and reduce side effects.
Method
A PRISMA-compliant review was conducted, screening studies from multiple databases, with a final inclusion of 64 in vivo studies.
Results
These studies highlighted plant extracts such as Ferula ammoniacum, Elaeagnus umbellata, Bacopa monnieri, and Centella asiatica, which improved memory, reduced oxidative stress, and provided neuroprotection. Some extracts also reduced amyloid plaques, enhanced neuronal integrity, and restored cholinesterase activity, indicating their potential as therapeutic agents for AD and other neurodegenerative diseases.
Conclusions
The findings underscore the promise of plant-based compounds in treating cognitive decline and cholinergic dysfunction in AD, advocating for further research into their therapeutic potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, College of Science, King Faisal University, P.O. Box No. 400, Al-Ahsa 31982, Saudi Arabia.
ORCID-Profile: Maryam N ALNasser
Förderung
- Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia
Zitieren
APA
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025). Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review. Brain Sciences, 15(2), 215. https://doi.org/10.3390/brainsci15020215
Vancouver
ALNasser MN, Alboraiy GM, Alsowig EM, Alqattan FM. Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review. Brain Sciences. 2025;15(2):215. doi:10.3390/brainsci15020215
BibTeX
@article{ALNasser2025,
author = {ALNasser, Maryam N and Alboraiy, Ghadir M and Alsowig, Eman M and Alqattan, Fatimah M},
title = {Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review},
journal = {Brain Sciences},
year = {2025},
volume = {15},
number = {2},
pages = {215},
doi = {10.3390/brainsci15020215}
}
EUVIMED